ProfileGDS4132 / 1558481_s_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 21% 16% 30% 62% 25% 22% 30% 21% 34% 46% 45% 44% 34% 51% 69% 53% 46% 32% 48% 37% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10146.226121
GSM201543Muscle PCOS pioglitazone 12128.038816
GSM201544Muscle PCOS pioglitazone 16177.775530
GSM201545Muscle PCOS pioglitazone 201184.89662
GSM201829Muscle PCOS pioglitazone 23164.216725
GSM201830Muscle PCOS pioglitazon 25152.844322
GSM201831Muscle PCOS pioglitazone 27172.909830
GSM201832Muscle PCOS pioglitazone 3148.3121
GSM201833Muscle PCOS pioglitazone 4179.399834
GSM201834Muscle PCOS pioglitazone 81119.69446
GSM201835Muscle PCOS after pioglitazone 102103.26145
GSM201836Muscle PCOS after pioglitazone 122106.04144
GSM201837Muscle PCOS after pioglitazone 16269.852334
GSM201838Muscle PCOS after pioglitazone 202127.66351
GSM201839Muscle PCOS after pioglitazone 232203.14869
GSM201840Muscle PCOS after pioglitazone 252140.47153
GSM201841Muscle PCOS after pioglitazone 272106.46946
GSM201842Muscle PCOS after pioglitazone 3262.876632
GSM201843Muscle PCOS after pioglitazone 42122.77848
GSM201844Muscle PCOS after pioglitazone 8289.409237